Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.53 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TGM2 | P21980 | 16/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15132326 | 0.84 | ZDHHC20 (0.51) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL5058982 | 0.80 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL905081 | 0.80 | ZDHHC20 (0.44) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL632264 | 0.80 | ZDHHC20 (0.75) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL5052477 | 0.79 | ZDHHC20 (0.54) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL15132327 | 0.79 | ZDHHC20 (0.46) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL270209 | 0.78 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL58169 | 0.78 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL8405507 | 0.78 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 | |
| SCHEMBL1592093 | 0.78 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140350205-A1 | NOVEL SHEAR-RESISTANT POLYMER SYSTEMS, PRODUCTION THEREOF, AND ALSO USE THEREOF AS THICKENERS | POLYPREC GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| US-20110002862-A1 | Method For The Production Of Polymers By Means Of Ion Exchange | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-01-06 | — | — | US | disclosed |
| US-7297823-B2 | Additives for inhibiting the formation of gas hydrates | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2007-11-20 | — | — | US | disclosed |
| US-20060142159-A1 | Plant-protective agents in the form of suspensions | MEYER GERD R | 2006-06-29 | — | — | US | disclosed |
| US-20060030486-A1 | Crystallization inhibitor for plant-protective formulations | CLARIANT GMBH | 2006-02-09 | — | — | US | disclosed |
| US-20050182219-A1 | Crystallization inhibitor for plant-protective formulations | MEYER GERD R (DE) | 2005-08-18 | — | — | US | disclosed |
| US-20040030206-A1 | Additives for inhibiting the formation of gas hydrates | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040030206-A1 | Additives for inhibiting the formation of gas hydrates | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AQP1, CCNT1 | ZDHHC20 1201/4885ZDHHC2 1770/4885ALDH1A1 282/4885 |
| US-20110002862-A1 | Method For The Production Of Polymers By Means Of Ion Exchange | H1-0, KCNH3, KCNMA1 | ZDHHC20 700/4885ZDHHC2 855/4885ALDH1A1 2793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.